Trust Point Inc. Purchases 622 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Trust Point Inc. lifted its position in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 2.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 24,124 shares of the company’s stock after purchasing an additional 622 shares during the period. Trust Point Inc.’s holdings in Option Care Health were worth $755,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. lifted its holdings in shares of Option Care Health by 1.6% during the fourth quarter. Vanguard Group Inc. now owns 19,626,205 shares of the company’s stock worth $661,207,000 after purchasing an additional 306,853 shares during the period. PNC Financial Services Group Inc. raised its position in shares of Option Care Health by 17.4% during the fourth quarter. PNC Financial Services Group Inc. now owns 29,374 shares of the company’s stock worth $990,000 after acquiring an additional 4,350 shares during the last quarter. Congress Asset Management Co. MA lifted its stake in shares of Option Care Health by 26.5% in the first quarter. Congress Asset Management Co. MA now owns 257,580 shares of the company’s stock worth $8,639,000 after acquiring an additional 54,011 shares during the period. Rheos Capital Works Inc. boosted its holdings in Option Care Health by 9.8% in the first quarter. Rheos Capital Works Inc. now owns 357,600 shares of the company’s stock valued at $11,994,000 after acquiring an additional 32,000 shares during the last quarter. Finally, Park Place Capital Corp increased its position in Option Care Health by 48.4% during the 1st quarter. Park Place Capital Corp now owns 1,140 shares of the company’s stock valued at $38,000 after purchasing an additional 372 shares during the period. Institutional investors and hedge funds own 98.05% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on OPCH shares. JMP Securities upped their price objective on shares of Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a research note on Monday, September 30th. Barrington Research increased their price target on Option Care Health from $38.00 to $40.00 and gave the stock an “outperform” rating in a report on Thursday, August 1st.

Option Care Health Trading Up 2.3 %

NASDAQ:OPCH opened at $31.64 on Friday. The firm has a fifty day simple moving average of $31.09 and a two-hundred day simple moving average of $30.16. Option Care Health, Inc. has a 12 month low of $26.11 and a 12 month high of $34.63. The stock has a market capitalization of $5.50 billion, a price-to-earnings ratio of 20.82, a PEG ratio of 2.21 and a beta of 1.29. The company has a current ratio of 1.76, a quick ratio of 1.36 and a debt-to-equity ratio of 0.78.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings results on Wednesday, July 31st. The company reported $0.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.03. The business had revenue of $1.23 billion for the quarter, compared to analyst estimates of $1.17 billion. Option Care Health had a return on equity of 14.82% and a net margin of 4.60%. The company’s quarterly revenue was up 14.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.63 earnings per share. Analysts expect that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Insider Buying and Selling at Option Care Health

In related news, Director Elizabeth Quadros Betten sold 47,531 shares of the firm’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total value of $1,477,738.79. Following the transaction, the director now owns 21,339 shares of the company’s stock, valued at approximately $663,429.51. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Option Care Health news, Director Elizabeth Quadros Betten sold 47,531 shares of Option Care Health stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the transaction, the director now directly owns 21,339 shares of the company’s stock, valued at $663,429.51. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Michael H. Shapiro sold 23,217 shares of the company’s stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total transaction of $718,566.15. Following the completion of the sale, the chief financial officer now owns 247,317 shares of the company’s stock, valued at approximately $7,654,461.15. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.64% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.